MarketPeel
Insider Trading Intelligence
Pricing
…
KJ

Khurram Jamil

GALT
CHIEF MEDICAL OFFICER · GALECTIN THERAPEUTICS INC · CIK 0002032345
FILING MIX · LIFETIME42%/58%
BUYS
20
SELLS
28
TOTAL VALUE
$1.54M
COMPANIES
1
ACTIVE SINCE
Aug 2024
HOLDINGS NOW
47,467
AVG SELL PX
$4.72
TRADE KIND
SHOWING 48 / 48
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 21 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Khurram Jamil, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+63.64%-13.17%+0.25%-13.42%-16.03%—
14d11+63.64%-13.64%+0.65%-14.29%-21.46%—
30d11+63.64%-16.69%+1.49%-18.18%-23.49%—
60d11+90.91%-28.75%+1.00%-29.76%-46.30%—
90d11+90.91%-31.42%-1.10%-30.32%-51.22%—
180d11+54.55%-11.38%+8.49%-19.87%-68.88%—
1y11(10 pending)+0.00%+348.26%+16.03%+332.23%+332.23%—
2y11(11 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GALT · 47,467 shares · as of Jun 29, 2026
027,12554,25081,375108,50020252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 28 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
47,467$2.50$118.7K47,467Jun 29, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
47,467$5.04$239.2K0Jun 29, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
47,467——0Jun 29, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
2,533$5.00$12.7K0Jun 26, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
2,037$2.20$4.5K2,037Jun 26, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
2,037——100,000Jun 26, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
2,037$5.00$10.2K0Jun 26, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
2,533$2.50$6.3K2,533Jun 26, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
2,533——47,467Jun 26, 2026Jun 30, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
7,557$1.23$9.3K7,557Jun 23, 2026Jun 25, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
7,557$3.14$23.7K0Jun 23, 2026Jun 25, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
7,557——32,500Jun 23, 2026Jun 25, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
568$1.23$699568May 26, 2026May 28, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
568——40,057May 26, 2026May 28, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
568$3.10$1.8K0May 26, 2026May 28, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
100,000——100,000Jan 16, 2026Jan 21, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
65,000——65,000Jan 16, 2026Jan 21, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
21,446$3.65$78.2K0Jan 6, 2026Jan 6, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
25,499$3.90$99.4K21,446Jan 5, 2026Jan 6, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
60,000——60,000Jan 2, 2026Jan 6, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
13,055$4.20$54.8K46,945Jan 2, 2026Jan 6, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
60,000——0Jan 1, 2026Jan 6, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
8,125——40,625Dec 31, 2025Jan 5, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
8,125$4.07$33.1K0Dec 31, 2025Jan 5, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
8,125$1.23$10.0K8,125Dec 31, 2025Jan 5, 2026 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
8,500$2.50$21.3K8,500Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
4,479$7.04$31.5K0Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
8,500$7.04$59.8K0Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
6,463——102,037Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
8,500——50,000Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
6,463$7.04$45.5K0Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
6,463$2.20$14.2K6,463Dec 17, 2025Dec 19, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
41,500$5.47$227.0K4,479Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
21,867$5.47$119.6K4,479Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
16,250——48,750Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
16,250$1.23$20.0K20,729Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
41,500$2.50$103.8K45,979Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
41,500$2.20$91.3K45,979Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
41,500——108,500Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
16,250$5.47$88.9K4,479Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE
Chief Medical Officer
41,500——58,500Nov 13, 2025Nov 14, 2025 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
60,000——60,000Jan 23, 2025Aug 5, 2024 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
65,000——65,000Jan 23, 2025Aug 5, 2024 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
40,000——40,000Dec 23, 2024Dec 26, 2024 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
Chief Medical Officer
40,000——0Dec 23, 2024Dec 26, 2024 ↗View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
13,654$0.88$12.0K26,346Dec 23, 2024Dec 26, 2024 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
100,000——100,000Aug 1, 2024Aug 5, 2024 ↗View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
10,000——10,000Aug 1, 2024Aug 5, 2024 ↗View →
Other insiders · GALT
Loading peer insiders…
About this filer
CIK 0002032345
ROLE
Chief Medical Officer
PRIMARY
GALT
COMPANIES
1
ACTIVE SINCE
Aug 2024
MARKETPEEL · /INSIDER/0002032345DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback